KalVista Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
KalVista Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Current Ratio for the quarter ending July 31, 2024 was 792 %, a 38% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 792 -486 -38% Jul 31, 2024
Q1 2024 824 -615 -42.7% Apr 30, 2024
Q4 2023 840 -759 -47.5% Jan 31, 2024
Q3 2023 1.1K -627 -36.4% Oct 31, 2023
Q2 2023 1.28K -702 -35.5% Jul 31, 2023
Q1 2023 1.44K -817 -36.2% Apr 30, 2023
Q4 2022 1.6K -951 -37.3% Jan 31, 2023
Q3 2022 1.73K -616 -26.3% Oct 31, 2022
Q2 2022 1.98K +74.9 +3.93% Jul 31, 2022
Q1 2022 2.26K +858 +61.4% Apr 30, 2022
Q4 2021 2.55K +1.61K +171% Jan 31, 2022
Q3 2021 2.34K +1.38K +144% Oct 31, 2021
Q2 2021 1.9K +872 +84.5% Jul 31, 2021
Q1 2021 1.4K +416 +42.4% Apr 30, 2021
Q4 2020 942 +103 +12.3% Jan 31, 2021
Q3 2020 958 +203 +26.9% Oct 31, 2020
Q2 2020 1.03K +356 +52.6% Jul 31, 2020
Q1 2020 981 +455 +86.4% Apr 30, 2020
Q4 2019 839 +409 +95.3% Jan 31, 2020
Q3 2019 755 +415 +122% Oct 31, 2019
Q2 2019 676 +385 +132% Jul 31, 2019
Q1 2019 526 +180 +51.9% Apr 30, 2019
Q4 2018 429 -47.4 -9.95% Jan 31, 2019
Q3 2018 341 -665 -66.1% Oct 31, 2018
Q2 2018 291 -866 -74.8% Jul 31, 2018
Q1 2018 347 -1.11K -76.2% Apr 30, 2018
Q4 2017 477 -1.01K -67.8% Jan 31, 2018
Q3 2017 1.01K -486 -32.6% Oct 31, 2017
Q2 2017 1.16K -316 -21.4% Jul 31, 2017
Q1 2017 1.45K +5.89 +0.41% Apr 30, 2017
Q4 2016 1.48K +674 +83.5% Jan 31, 2017
Q3 2016 1.49K +965 +183% Sep 30, 2016
Q2 2016 1.47K Jun 30, 2016
Q1 2016 1.45K Mar 31, 2016
Q4 2015 808 Dec 31, 2015
Q3 2015 527 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.